Prothena Corporation PLC
PRTA6.945USD
+0.135+1.98%
Horário de mercado （ET）Cotações atrasadas em 15 min
373.83MValor de mercado
PerdaP/L TTM
Mais detalhes de Prothena Corporation PLC Empresa
Prothena Corporation plc is an Ireland-based late-stage clinical biotechnology company. The Company is engaged in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid diseases. The Company is advancing a pipeline of therapeutic candidates for a range of indications and targets to integrate scientific insights around neurological dysfunction and the biology of misfolded proteins. The Company’s pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases, including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and a range of other neurodegenerative diseases. Its clinical programs include birtamimab for the potential treatment of AL amyloidosis, prasinezumab for the potential treatment of Parkinson’s disease, NNC6019/PRX004 for the potential treatment of ATTR amyloidosis, and PRX005 and PRX012 for the potential treatment of Alzheimer’s disease.
Informações da empresa
Código da empresaPRTA
Nome da EmpresaProthena Corporation PLC
Data de listagemDec 21, 2012
CEODr. Gene G. Kinney, Ph.D.
Número de funcionários163
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 21
Endereço77 Sir John Rogerson's Quay, Block C
CidadeDUBLIN
Bolsa de valoresNASDAQ Global Select Consolidated
PaísIreland
Código postalD02 VK60
Telefone35312362500
Sitehttps://www.prothena.com/
Código da empresaPRTA
Data de listagemDec 21, 2012
CEODr. Gene G. Kinney, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brandon S. Smith
Mr. Brandon S. Smith
Chief Operating Officer
Chief Operating Officer
130.00K
--
Dr. Wagner M. Zago, Ph.D.
Dr. Wagner M. Zago, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
85.00K
--
Dr. Dennis J. Selkoe, M.D.
Dr. Dennis J. Selkoe, M.D.
Independent Director
Independent Director
4.21K
--
Mr. Richard T. Collier
Mr. Richard T. Collier
Independent Director
Independent Director
1.22K
--
Dr. Lars G. Ekman, M.D., Ph.D.
Dr. Lars G. Ekman, M.D., Ph.D.
Chairman Emeritus
Chairman Emeritus
243.00
--
Mr. Daniel G. Welch
Mr. Daniel G. Welch
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Shane M. Cooke
Mr. Shane M. Cooke
Independent Director
Independent Director
--
--
Ms. Karin L. Walker, CPA
Ms. Karin L. Walker, CPA
Chief Accounting Officer
Chief Accounting Officer
--
--
Ms. Paula K. Cobb
Ms. Paula K. Cobb
Independent Director
Independent Director
--
--
Ms. Helen S. Kim
Ms. Helen S. Kim
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brandon S. Smith
Mr. Brandon S. Smith
Chief Operating Officer
Chief Operating Officer
130.00K
--
Dr. Wagner M. Zago, Ph.D.
Dr. Wagner M. Zago, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
85.00K
--
Dr. Dennis J. Selkoe, M.D.
Dr. Dennis J. Selkoe, M.D.
Independent Director
Independent Director
4.21K
--
Mr. Richard T. Collier
Mr. Richard T. Collier
Independent Director
Independent Director
1.22K
--
Dr. Lars G. Ekman, M.D., Ph.D.
Dr. Lars G. Ekman, M.D., Ph.D.
Chairman Emeritus
Chairman Emeritus
243.00
--
Mr. Daniel G. Welch
Mr. Daniel G. Welch
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: sáb, 7 de jun
Atualizado em: sáb, 7 de jun
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
14.75%
Scully (William P)
10.42%
Fennell (Todd W.)
8.53%
T. Rowe Price Associates, Inc.
6.29%
BlackRock Institutional Trust Company, N.A.
6.10%
Other
53.91%
Investidores
Investidores
Proporção
Fidelity Management & Research Company LLC
14.75%
Scully (William P)
10.42%
Fennell (Todd W.)
8.53%
T. Rowe Price Associates, Inc.
6.29%
BlackRock Institutional Trust Company, N.A.
6.10%
Other
53.91%
Tipos de investidores
Investidores
Proporção
Investment Advisor
41.72%
Individual Investor
18.99%
Hedge Fund
12.64%
Investment Advisor/Hedge Fund
10.92%
Venture Capital
5.48%
Research Firm
2.58%
Bank and Trust
0.65%
Pension Fund
0.21%
Sovereign Wealth Fund
0.11%
Other
6.70%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
457
50.26M
93.38%
-20.92M
2025Q1
472
64.29M
119.45%
-7.39M
2024Q4
479
65.24M
121.19%
+239.99K
2024Q3
476
59.39M
110.43%
-5.39M
2024Q2
479
58.48M
108.76%
-4.67M
2024Q1
472
60.86M
113.29%
-264.94K
2023Q4
474
56.64M
105.77%
-2.21M
2023Q3
476
55.90M
104.65%
-1.73M
2023Q2
475
55.02M
104.46%
-3.12M
2023Q1
464
54.98M
104.68%
-658.88K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Fidelity Management & Research Company LLC
7.94M
14.75%
-129.91K
-1.61%
Mar 31, 2025
Scully (William P)
5.61M
10.42%
-36.34K
-0.64%
Mar 31, 2025
Fennell (Todd W.)
4.59M
8.53%
-54.34K
-1.17%
Mar 31, 2025
T. Rowe Price Associates, Inc.
3.38M
6.29%
-232.75K
-6.43%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.29M
6.1%
-61.73K
-1.84%
Mar 31, 2025
Logos Global Management LP
2.95M
5.48%
+2.95M
--
May 29, 2025
Armistice Capital LLC
2.20M
4.08%
-40.00K
-1.79%
Mar 31, 2025
Palo Alto Investors LP
1.66M
3.08%
-78.23K
-4.50%
Mar 31, 2025
State Street Global Advisors (US)
1.52M
2.83%
-340.28K
-18.28%
Mar 31, 2025
Invus Public Equities Advisors, LLC
1.28M
2.38%
+183.72K
+16.70%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 2 de ago
Atualizado em: sáb, 2 de ago
Nome
Proporção
Virtus LifeSci Biotech Clinical Trials ETF
1.08%
iShares Neuroscience and Healthcare ETF
0.63%
Invesco NASDAQ Future Gen 200 ETF
0.6%
Tema Neuroscience and Mental Health ETF
0.3%
Federated Hermes MDT Small Cap Core ETF
0.3%
ALPS Medical Breakthroughs ETF
0.22%
Invesco Nasdaq Biotechnology ETF
0.04%
iShares ESG Aware MSCI USA Small-Cap ETF
0.04%
ProShares Ultra Nasdaq Biotechnology
0.04%
iShares Biotechnology ETF
0.03%
Ver Mais
Virtus LifeSci Biotech Clinical Trials ETF
Proporção1.08%
iShares Neuroscience and Healthcare ETF
Proporção0.63%
Invesco NASDAQ Future Gen 200 ETF
Proporção0.6%
Tema Neuroscience and Mental Health ETF
Proporção0.3%
Federated Hermes MDT Small Cap Core ETF
Proporção0.3%
ALPS Medical Breakthroughs ETF
Proporção0.22%
Invesco Nasdaq Biotechnology ETF
Proporção0.04%
iShares ESG Aware MSCI USA Small-Cap ETF
Proporção0.04%
ProShares Ultra Nasdaq Biotechnology
Proporção0.04%
iShares Biotechnology ETF
Proporção0.03%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
